WallStSmart
CMND

Clearmind Medicine Inc. Common Shares

NASDAQ: CMND · HEALTHCARE · BIOTECHNOLOGY

$0.52
+36.77% today

Updated 2026-06-05

Market cap
$4.06M
P/E ratio
P/S ratio
EPS (TTM)
$-241.20
Dividend yield
52W range
$2 – $524
Volume
9.2M

WallStSmart proprietary scores

26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
6.0
Quality
B
3.0
Profitability
D
5.0
Valuation
C+
1/9
Piotroski F-Score
Weak
-8.1
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

Stock snapshot

Strengths
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -8.11 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-2.08M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-9.93M$-8.61M$-5.25M$-3.86M$-3.85M
EPS$-241.20
Free cash flow$-5.06M$-6.30M$-6.76M$-4.73M$-2.08M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CMND$4.06M264.33.05.06.0Avoid
LLY$948.95B7810.010.05.06.0Strong Buy
JNJ$536.54B594.79.03.36.0-71.41%Buy
ABBV$380.57B634.08.04.05.0-55.64%Buy
UNH$343.21B545.35.54.75.5-26.61%Buy
MRK$285.64B503.38.02.75.0-49.34%Hold

Smart narrative

Clearmind Medicine Inc. Common Shares trades at $0.52. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -8.11, it sits in the distress.

Frequently asked questions

What is Clearmind Medicine Inc. Common Shares's stock price?

Clearmind Medicine Inc. Common Shares (CMND) trades at $0.52.

Is Clearmind Medicine Inc. Common Shares overvalued?

Clearmind Medicine Inc. Common Shares carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Clearmind Medicine Inc. Common Shares's Altman Z-Score is -8.11, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-93.63%
Beta-1.24
50D MA$6.96
200D MA$133.85
Shares out0.00B
Float0.00B
Short ratio
Avg volume9.2M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years